BYRD v. INVENTIV HEALTH

CourtDistrict Court, D. New Jersey
DecidedApril 29, 2024
Docket3:23-cv-04227
StatusUnknown

This text of BYRD v. INVENTIV HEALTH (BYRD v. INVENTIV HEALTH) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
BYRD v. INVENTIV HEALTH, (D.N.J. 2024).

Opinion

NOT FOR PUBLICATION

UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY

TAKICIAN BYRD,

Plaintiff, Civil Action No. 23-4227 (ZNQ) (TJB)

v. OPINION

INVENTIV HEALTH, et al.,

Defendants.

QURAISHI, District Judge THIS MATTER comes before the Court upon Defendant AbbVie Inc.’s (“AbbVie”) Motion to Dismiss (ECF No. 9) and Defendants Syneos Health US, Inc. (“Syneos”),1 inVentiv Health (“inVentiv”),2 PharmaNet Resource Solutions (“PharmaNet”),3 and Tammy Bainbridge’s (“Bainbridge”) (together, the “Syneos Defendants”) Motion to Dismiss (ECF No. 16). On September 8, 2023, in support of its Motion to Dismiss, AbbVie filed a Moving Brief. (“AbbVie’s Moving Br., ECF No. 9.) Plaintiff Takician Byrd (“Plaintiff” or “Byrd”) opposed (“Opp’n”, ECF No. 11) and AbbVie replied. (“Reply”, ECF No. 14). In support of their Motion to Dismiss, the Syneos Defendants filed a Moving Brief. (“Syneos Defendants’ Moving Br.”, ECF No. 16-1.) Plaintiff did not oppose. Having reviewed the parties’ submissions filed in connection with the

1 Plaintiff improperly pleads Defendant Syneos’s name as “Syneos Health.” (See Compl. at 5.) 2 According to the Syneos Defendants, inVentiv “merged with another entity in 2018 to create Syneos, and is no longer an operating entity.” (Syneos Defendants’ Moving Br. at 1 n.2; Declaration of Robert M. Pettigrew, “Pettigrew Decl.”, ECF No. 16-2 ¶ 2.) 3 Plaintiff improperly pleads Defendant PharmaNet’s name as “Resource Solutions.” (See Compl. at 5.) According to the Syneos Defendants, “PharmaNet Resource Solutions was subsequently acquired and merged into the Syneos offerings and is no longer operating.” (Syneos Defendants’ Moving Br. at 1 n.2; Pettigrew Decl. ¶ 3.) Motions and having declined to hold oral argument pursuant to Federal Rule of Civil Procedure 78(b) and Local Civil Rule 78.1, for the reasons set forth below and for good cause appearing, the Court will GRANT AbbVie’s Motion and GRANT the Syneos Defendants’ Motion. Plaintiff’s claims will be dismissed with prejudice. I. BACKGROUND AND PROCEDURAL HISTORY

On July 5, 2022, pro se Plaintiff filed her Complaint (“Compl.”, ECF No. 1, Ex. A at 5– 31)4 in New Jersey Superior Court, Mercer County.5 On January 21, 2023, the New Jersey Superior Court dismissed the Complaint for lack of prosecution because Plaintiff had failed to properly serve Defendants. (See ECF No. 1 at 121–23.) On May 30, 2023, Plaintiff filed a Motion to Reinstate the Complaint (see id. at 126), which the New Jersey Superior Court granted on June 23, 2023. (See id. at 129). On August 8, 2023, Defendant AbbVie removed Plaintiff’s Complaint to this Court pursuant to 28 U.S.C. §§ 1331, 1441 and 1446. (See generally ECF No. 1.) According to AbbVie, Plaintiff served the Complaint on AbbVie on July 11, 2023, a year after filing her Complaint. (See AbbVie’s Moving Br. at 2.)6 The Complaint alleges employment

discrimination claims against AbbVie and the Syneos Defendants related to her use of leave under the Family Medical Leave Act of 1993 (FMLA), 29 U.S.C. § 2601 et seq. and her alleged disability status under the Americans with Disabilities Act of 1990 (ADA), 42 U.S.C. § 12101 et seq. (See Compl. at 6.) Plaintiff also appears to assert that post-employment recruiting communications

4 Plaintiff’s complaint and attachments are contained in the first 27 pages attached as Exhibit A to AbbVie’s Notice of Removal. Plaintiff attached numerous documents to her Complaint including a Civil Case Information Statement and a series of email chains purporting to show Plaintiff’s correspondence with AbbVie, her separate correspondence with individuals from Defendant Syneos, and emails forwarding these email chains to what appears to be the U.S. Department of Labor and the Equal Employment Opportunity Commission (EEOC). (See Compl. at 5-31.) 5 On August 22, 2022, Plaintiff filed a Motion for Summary Judgment with the New Jersey Superior Court, prior to serving any Defendants. (See ECF No. 1 at 34–120.) On September 23, 2022, the New Jersey Superior Court denied Plaintiff’s Motion for Summary Judgment. (See id. at 121–23.) 6 The Syneos Defendants contend that Plaintiff has still not properly effected service upon them, and that upon hearing that AbbVie had filed its Motion to Dismiss, the Syneos Defendants “voluntarily appeared in this action by filing the instant motion.” (Syneos Defendants’ Moving Br. at 1–3; Pettigrew Decl. ¶ 10.) between her and the Syneos Defendants between 2017 and 2022, which did not result in employment, violated her rights. (See id. at 5–31.) Defendant Syneos is “a fully integrated biopharmaceutical solutions organization that provides various contractual services to pharmaceutical companies.” (Syneos Defendants’ Moving Br. at 1–2; Pettigrew Decl. ¶ 2.) Defendant AbbVie is one such pharmaceutical company.

(Id.) In papers filed in state court, Plaintiff asserts that she was employed by the Syneos Defendants from March 2012 through August 2014. (See Plaintiff’s Certification in Support of Motion for Summary Judgment, “Super. Ct. SJ Cert.”, ECF No. 1 at 41; Plaintiff’s Brief in Support of Motion for Summary Judgment, “Super. Ct. SJ Br.”, ECF No. 1 at 46 ¶ 1; Pettigrew Decl. ¶ 11.)7 Plaintiff argues that on May 27, 2014 she requested a “continuous leave of absence” due to a “Serious Health Condition” under the FMLA, and her leave was granted for the period from May 20, 2014 until June 16, 2014. (See Super. Ct. SJ Br. at 118.) On July 31, 2023, Plaintiff communicated with a senior human resources associate at InVentiv (see id. at 60), who Plaintiff alleges was an “agent of Syneos [H]ealth.” (Id. at 46.) The associate informed Plaintiff that

Defendant Bainbridge (then a Manager at PharmaNet) would contact Plaintiff “once a decision ha[d] been reached” by Plaintiff’s management team about a return to work and “if your restrictions/limitations can be accommodated.” (Id. at 60.) On August 1, 2014, Plaintiff discussed with Bainbridge a return from family leave. (Id. at 46 ¶ 1.) Ms. Bainbridge allegedly informed

7 The allegations in Plaintiff’s Complaint itself are sparse—limited to a few paragraphs—and somewhat unclear. “As part of the effort to construe a pro se litigant’s pleadings liberally, however, [the Third Circuit has] held that it may be proper to consider certain material outside a pro se litigant’s complaint and exhibits when ruling on a motion to dismiss.” Rister v. Yadkin Bank, 714 F. App’x 170, 172–73 (3d Cir. 2017); see also Mack v. Warden Loretto FCI, 839 F.3d 286, 291 n.2 (3d Cir. 2016) (“[W]e will also consider his allegations made in response to the defendants’ motion to dismiss, which incorporate and are consistent with the allegations in his complaint.”). Therefore, in considering the instant Motion to Dismiss, the Court also considers the documents pertaining to Plaintiff’s Motion for Summary Judgment in the New Jersey Superior Court, Mercer County (see Super. Ct. SJ Cert. at 34–45; Super. Ct. SJ Br. at 46–121) and Plaintiff’s Motion to Reinstate the Complaint (see ECF No. 1 at 124–32), which are included with the Complaint and are consistent with the allegations in the Complaint.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Conley v. Gibson
355 U.S. 41 (Supreme Court, 1957)
Zipes v. Trans World Airlines, Inc.
455 U.S. 385 (Supreme Court, 1982)
Erickson v. Pardus
551 U.S. 89 (Supreme Court, 2007)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Karen Malleus v. John George
641 F.3d 560 (Third Circuit, 2011)
Kelley Mala v. Crown Bay Marina
704 F.3d 239 (Third Circuit, 2013)
Fowler v. UPMC SHADYSIDE
578 F.3d 203 (Third Circuit, 2009)
County of Morris v. Fauver
707 A.2d 958 (Supreme Court of New Jersey, 1998)
Christiana Itiowe v. NBC Universal Inc
556 F. App'x 126 (Third Circuit, 2014)
Vincent Mercer v. SEPTA
608 F. App'x 60 (Third Circuit, 2015)
Charles Mack v. Warden Loretto FCI
839 F.3d 286 (Third Circuit, 2016)
Timothy Rister v. Yadkin Bank
714 F. App'x 170 (Third Circuit, 2017)
Fitzgerald v. Shore Memorial Hospital
92 F. Supp. 3d 214 (D. New Jersey, 2015)
Thakar v. Tan
372 F. App'x 325 (Third Circuit, 2010)
Kehr Packages, Inc. v. Fidelcor, Inc.
926 F.2d 1406 (Third Circuit, 1991)

Cite This Page — Counsel Stack

Bluebook (online)
BYRD v. INVENTIV HEALTH, Counsel Stack Legal Research, https://law.counselstack.com/opinion/byrd-v-inventiv-health-njd-2024.